Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Current HCP Valuation Already Prices In Spin-Off Benefits, Says UBS

Share:

UBS provided its outlook on HCP, Inc. (NYSE: HCP). They continue to think the company's plan to spinoff its skilled nursing assets is a positive for the stock, but think the market already reflects benefit of spin.

According to the analysts, the motivation for the spin is the ability for QCP to accept more equity in HCRMC's OpCo in a tradeoff for a rent cut in the future, which would probably result in QCP shedding its REIT status since it cannot own more than 10 percent of that OpCo as a REIT (HCP already owns 10 percent).

"During the earnings call, management maintained a reserved tone that seemed to support the intent to be listed as a REIT initially while keeping flexibility to change its business model and/or corporate structure to provide the best long-term solution," added the analysts.

UBS reiterated its Neutral rating and raised the price target to $38 from $35. The new price target is based on the sum-of-the-parts valuation with a 17.5x 2017E AFFO multiple on HCP and 5.5x (9 percent dividend yield) for QCP.

Latest Ratings for HCP

DateFirmActionFromTo
Jun 2019UpgradesMarket PerformOutperform
Jan 2019UpgradesMarket PerformOutperform
Dec 2018UpgradesSector WeightOverweight

View More Analyst Ratings for HCP
View the Latest Analyst Ratings

Posted-In: Analyst Color Reiteration Analyst Ratings

 

Related Articles (HCP)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NUEMaintains61.0
MMCMaintains105.0
BTIDowngrades
DGMaintains142.0
MDLZMaintains52.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Baird Incrementally Positive On Tableau Software's Surprise CEO Announcement

CF Industries: Does The CF Stand For Cash Flow?